title: Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia.
authors.affiliation: Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. kando@juntendo.ac.jp
authors.forename: Katsutoshi
authors.initials: K
authors.lastname: Ando
authors.forename: Fumiyuki
authors.initials: F
authors.lastname: Takahashi
authors.forename: Shinji
authors.initials: S
authors.lastname: Motojima
authors.forename: Kei
authors.initials: K
authors.lastname: Nakashima
authors.forename: Norihiro
authors.initials: N
authors.lastname: Kaneko
authors.forename: Kazuei
authors.initials: K
authors.lastname: Hoshi
authors.forename: Kazuhisa
authors.initials: K
authors.lastname: Takahashi
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000276:immunology / Q000627:therapeutic use*; D002100:Cachexia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D018287:Carcinoma, Large Cell / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D019947:Receptors, Interleukin-6 / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D019947:Receptors, Interleukin-6; C502936:tocilizumab